AbbVie Claims Rinvoq Superiority To Dupixent In AD

 
• By Joseph Haas
  
Head to head battle
Rinvoq shows efficacy edge vs. Dupixent in head-to-head trial • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D